Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
All of Us Research Program, |
RCV003996490 | SCV004820744 | uncertain significance | Malignant hyperthermia, susceptibility to, 1 | 2023-05-15 | criteria provided, single submitter | clinical testing | This missense variant replaces serine with leucine at codon 427 of the RYR1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with central core disease (PMID: 16621918). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Gene |
RCV000056239 | SCV000087328 | pathologic | Central core myopathy | 2010-05-11 | no assertion criteria provided | curation | Converted during submission to Pathogenic. |
Leiden Muscular Dystrophy |
RCV000119465 | SCV000154372 | not provided | not provided | no assertion provided | not provided |